Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)

DSpace Repository

Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)

Author: Spohn, Simon K. B.; Zamboglou, Constantinos; Freitag, Martin T.; Brumberg, Joachim; Engel, Hannes; Gainey, Mark; Kamps, Marius; Toncheva, Paolina; Sprave, Tanja; Kirste, Simon; Sigle, August; Jilg, Cordula; Gratzke, Christian; Adebahr, Sonja; Mix, Michael; Bamberg, Fabian; Zschaeck, Sebastian; Ghadjar, Pirus
Tübinger Autor(en):
Zschaeck, Sebastian
Ghadjar, Pirus
Published in: Radiotherapy and Oncology (2025), Bd. 208, Article 110883
Verlagsangabe: Clare : Elsevier Ireland Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.radonc.2025.110883
ISSN: 0167-8140
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)